ProceduralDiagnosticOPCS S15.x

Punch biopsy technique

Punch ยท trephine biopsy ยท cylindrical biopsy

A punch biopsy uses a circular trephine cutting blade (2-8 mm) to obtain a full-thickness cylindrical core of skin including epidermis, dermis and superficial subcutis. It is the workhorse diagnostic biopsy for inflammatory dermatoses, autoimmune blistering disease, lymphoproliferative disorders, vasculitis and many tumours. Closure is by primary closure or healing by secondary intention, according to size, site and patient factors. UK BAD minor-skin-surgery guidelines, BSDS standards and pathology RCPath dataset principles guide best practice.

CurrentLast reviewed 16 May 2026

Indications

  • Inflammatory dermatoses: eczema, psoriasis, lichen planus, lupus erythematosus.
  • Autoimmune blistering: bullous pemphigoid (lesional + perilesional for DIF).
  • Granulomatous: sarcoidosis, granuloma annulare, necrobiosis lipoidica.
  • Cutaneous lymphoma โ€” multiple sites for diagnostic yield.
  • Vasculitis.
  • Connective tissue disease (morphoea, scleroderma, dermatomyositis).
  • Small to medium tumours (BCC, melanocytic naevus, neurofibroma) โ€” diagnostic only.
  • Suspected pigmented lesions if clear margin assessment not required (full excision generally preferred for suspected melanoma; refer below).
  • Mucosal biopsies (oral, genital).

Technique

  1. Pre-procedure: explain, consent, mark site / orientation, photograph.
  2. Local anaesthesia: lidocaine 1-2% ยฑ adrenaline (avoid in digital end-arteries unless using established adrenaline-safe protocol).
  3. Antiseptic prep: chlorhexidine 0.5-2% or povidone-iodine; sterile drape.
  4. Select trephine size:
    • 2-3 mm: diagnostic biopsy where minimal scarring required.
    • 4 mm: standard inflammatory / tumour diagnostic.
    • 5-6 mm: larger lesions, deeper tumours, where adequate dermis needed.
    • 8 mm: deeper biopsy (subcutaneous panniculitis, dense infiltrates).
  5. Skin tension: stretch skin perpendicular to RSTL โ†’ final wound becomes oval.
  6. Rotation: hold trephine perpendicular to skin; rotate with downward pressure through full epidermis + dermis until subcutaneous fat is reached.
  7. Lift gently with fine-tooth forceps or skin hook; avoid crushing.
  8. Cut base with iris scissors at subcutaneous level.
  9. Place in fixative: 10% buffered formalin for routine; Michel medium / saline for DIF; PBS / fresh for molecular / electron microscopy.
  10. Closure:
    • Small punches: secondary intention or simple primary closure.
    • Intermediate punches: simple interrupted closure where needed.
    • Larger punches: layered closure where depth or tension requires it.

Pitfalls and limitations

  • Inadequate depth in panniculitis (need deep wedge or excisional rather than punch).
  • Crush artefact with rough handling โ€” distorts pathology.
  • Pigmented lesions: punch biopsy may sample a non-representative area; complete excisional biopsy preferred for suspected melanoma (NICE NG14).
  • Lower-leg / shin biopsies: high risk of poor healing; counsel.
  • Bleeding risk: appropriate haemostasis (ferric sulphate, electrocautery).
  • Wrong site: photograph and mark; specimen-mapping for multiple biopsies.
  • Inadequate IHC: send for indicated specialist markers (e.g. TCR rearrangement for CTCL).

Aftercare

  • If sutures used, typically removed at 7-14 days depending on site.
  • Emollient use when dressings no longer required; sun protection.
  • Counsel about scar formation; photograph at follow-up.
  • Communicate biopsy result via timely pathway (2-week-wait or routine).

References

  1. Mohs FE. Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg. 1941;42:279-295. (Historical context)
  2. British Association of Dermatologists. Staffing and Facilities Guidance for Skin Surgery Dermatology Services. London: BAD; version 4, updated June 2014; accessed 18 May 2026.
  3. Vanderhooft SL. Punch biopsy. StatPearls. Treasure Island: StatPearls Publishing; 2024.
  4. NICE NG14. Melanoma: assessment and management. London: NICE; 2015 (last updated 27 July 2022).

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.